Pharmaceutical Processing

Pharmaceutical Processing

The most fundamental change facing this sector is the shift toward personalised healthcare with targeted therapeutic interventions leading toward growth in innovative delivery mechanisms, companion diagnostics, niche busters and an increase in biologics. The shift toward biologics and nicheslide0023_image125 busters is seeing consolidation in the market, increased complexity in manufacturing processes, new materials and packaging and the need for firms to have cold chain logistics management capabilities to ensure that the manufacturer’s FDA approved storage conditions are carefully observed along the distribution chain.

Across the sector, the level of sophistication in manufacturing is increasing, requiring multi- disciplinary capabilities, new processes and analytical methods, shorter product runs and multi- product ‘flexible’ factories, as companies improve their abilities to adjust to ever-changing market demands.

slide0023_image123